Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2020, Vol. 47 Issue (1): 37-40    DOI: 10.31083/j.ceog.2020.01.4966
Original Research Previous articles | Next articles
Can pregnancy following muscle-sparing transverse abdominis myocutaneous (MS-TRAM) flaps be safe on abdominal wall?
K.-C. Moon1, J.-M. Lee1, E.-S. Yoon1, *(), B.-I. Lee1, S.-H. Park1
1Department of Plastic and Reconstructive Surgery, Korea University Anam Hospital, Seoul, Republic of Korea
Download:  PDF(8023KB)  ( 214 ) Full text   ( 14 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Objective: The purpose of this study is to investigate patients with pregnancy following muscle-sparing transverse abdominis myocutaneous (MS-TRAM) flaps and introduce some cases to determine outcomes including safety and timing of pregnancy following MSTRAM flap. Materials and Methods: A retrospective review of 917 breast reconstruction between March 2000 and September 2017 was performed. Of these 917 patients, 35 patients aged under 40 years visited the Department of Obstetrics following breast reconstructions using MS-TRAM flaps. Pregnancy following MS-TRAM flaps was determined by reviewing medical records and/or telephone interviews. Results: Two patients were followed up accordingly and they proceeded to delivery. Postpartum follow-up showed no complication. No evidence of disease or abdominal wall complication was found during a maximum of nine years. Conclusions: This case study highlights successful pregnancy following MS-TRAM flap within the shortest interval after surgery.

Key words:  Abdominal wall      Breast reconstruction      Delivery      Fascia      Pregnancy      TRAM     
Published:  15 February 2020     
*Corresponding Author(s):  E.-S. Yoon     E-mail:  yesanam2@korea.ac.kr

Cite this article: 

K.-C. Moon, J.-M. Lee, E.-S. Yoon, B.-I. Lee, S.-H. Park. Can pregnancy following muscle-sparing transverse abdominis myocutaneous (MS-TRAM) flaps be safe on abdominal wall?. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 37-40.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2020.01.4966     OR     https://ceog.imrpress.com/EN/Y2020/V47/I1/37

Figure 1.  — Flow chart of patients included in this study (n = number of patients).

Figure 2.  — Abdominal CT showing a fetus at 28 weeks of gestation after MS-TRAM flap. Axial view (left), and coronal view (right).

Figure 3.  — A patient became pregnant just before MS-TRAM flap. Postoperative photograph of patient at five weeks after MS-TRAM flap (left). Postoperative photograph at 4 months after surgery (20 weeks of gestation) (middle). Postoperative photograph at ten months after surgery (1.5 months after delivery) (right).

Figure 4.  — An intraoperative photograph after flap harvest of MS-TRAM flap.

Figure 5.  — A patient became pregnant after six months following MS-TRAM flap. Preoperative photograph of patient with design for MS-TRAM flap (left). Postoperative photograph at three years after surgery (1.8 years after delivery) (right).

[1] Chai S.C., Umayaal S., Saad A.Z.: “Successful pregnancy “during” pedicled transverse rectus abdominis musculocutaneous flap for breast reconstruction with normal vaginal delivery”. Indian. J. Plast. Surg., 2015, 48, 81.
[2] Parodi P.C., Osti M., Longhi P., Rampino E., Anania G., Riberti C.: “Pregnancy and tram-flap breast reconstruction after mastectomy: a case report”. Scand. J. Plast. Reconstr. Surg. Hand. Surg., 2001, 35, 211.
[3] Zeligson G., Hadar A., Koretz M., Silberstein E., Krieger Y., Bogdanov-Berezovsky A.: “Uneventful pregnancy and delivery after TRAM flap reconstruction following bilateral mastectomies”. Isr. Med. Assoc. J., 2011, 13, 381.
[4] Won Y.J., Sung J., Jung K.W., Kong H.J., Park S., Shin H.R., et al.: “Nationwide cancer incidence in Korea, 2003-2005”. Cancer. Res. Treat., 2009, 41, 122-31.
[5] Carramaschi F.R., Ramos M.L., Pinotti J.A., Ferreira M.C.: “Pregnancy Following Breast Reconstruction with TRAM Flaps”. Breast J., 1998, 4, 258.
[6] Wagner L.H., Ruth-Sahd L.A.: “Pregnancy after a TRAM flap procedure: principles of nursing care”. J. Obstet. Gynecol. Neonatal. Nurs., 2000, 29, 363.
[7] Bhat W., Akhtar S., Akali A.: “Pregnancy in the early stages following DIEP flap breast reconstruction—a review and case report”. J. Plast. Reconstr. Aesthet. Surg., 2010, 63, e782.
[8] Nahabedian M.Y., Tsangaris T., Momen B.: “Breast reconstruction with the DIEP flap or the muscle-sparing(MS-2) free TRAM flap: is there a difference?”. Plast. Reconstr. Surg., 2005, 115, 436.
[9] Bajaj A.K., Chevray P.M., Chang D.W.: “Comparison of donor-site complications and functional outcomes in free muscle-sparing TRAM flap and free DIEP flap breast reconstruction”. Plast. Reconstr. Surg., 2006, 117, 737.
[10] Momeni A., Kim R.Y., Heier M., Bannasch H., Stark G.B.: “Abdominal wall strength: a matched-pair analysis comparing muscle-sparing TRAM flap donor-site morbidity with the effects of abdominoplasty”. Plast. Reconstr. Surg., 2010, 126, 1454.
[11] Selber J.C., Fosnot J., Nelson J., Goldstein J., Bergey M., Sonnad S., et al.: “A prospective study comparing the functional impact of SIEA, DIEP, and muscle-sparing free TRAM flaps on the abdominal wall: Part II. Bilateral reconstruction”. Plast. Reconstr. Surg., 2010, 126, 1438.
[12] Man L.X., Selber J.C., Serletti J.M.: “Abdominal wall following free TRAM or DIEP flap reconstruction: a meta-analysis and critical review”. Plast. Reconstr. Surg., 2009, 124, 752.
[1] Ali S. Alqahtani. Seroprevalence of Dengue virus among pregnant mothers and their-newborn infants in the southwest of Saudi Arabia[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 741-743.
[2] M. Elmahdy, I. Elfourtia, H. Maghraby. Office hysteroscopy in cases of recurrent implantation failure; Do or not to do[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 723-728.
[3] L.L. Xu, J.Q. Li, Y.Q. Pu, C. Zhou, S.W. Feng, Q. Luo. Effect of prenatal depression during late pregnancy on maternal and neonatal outcomes[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 681-686.
[4] Y.X. Wang, M. Zhong, H. Yi, H.F. He. Detection of group B streptococcus colonization in cervical and lower vaginal secretions of pregnant women[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 669-674.
[5] I.F. Urunsak, U.K. Gulec, E. Eser, M. Sucu, C. Akcabay, S. Buyukkurt. The role of dinoprostone for labor induction in postterm and high-risk term pregnancies[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 664-668.
[6] S. Han, S. Choi, S. Nah, Y.H. Lee. Preterm labor in mild carbon monoxide poisoning: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 805-806.
[7] H.S.O. Abduljabbar, H. Abduljabar. A systematic review and meta-analysis of the reported symptoms of Covid 19 in pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 632-637.
[8] M. Varras, C. Loukas, N. Nikiteas, V.K. Varra, F.N. Varra, E. Georgiou. Comparison of laparoscopic surgical skills acquired on a virtual reality simulator and a box trainer: an analysis for obstetrics-gynecology residents[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 755-763.
[9] S. Srisukho, K. Srisupundit, T. Tongsong. Fulfillment of the criteria for diagnosis of cephalo-pelvic disproportion: ACOG guidelines[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 500-504.
[10] N. Dropińska, K. Chmaj-Wierzchowska, M. Wojciechowska, M. Wilczak. What is the state of knowledge on preterm birth?[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 505-510.
[11] H. Yolli, M.E. Demir, R. Yildizhan. Neutrophil gelatinase associated lipocalin-2 (Ngal) levels in preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 519-523.
[12] K. Chikazawa, K. Imai, T. Kuwata, K. Takagi. Prophylactic laparoscopic adnexal surgery with low-pressure CO2 insufflation for ovarian cysts during the late first trimester or second trimester of pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 537-540.
[13] G. Sel, A. Barut, Ü. Özmen, A. Y. Akdemir, S. Harma, B. Aynalı, M. Harma, M.İ. Harma. Mode of delivery does not have a relationship with high-risk HPV positivity[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 541-545.
[14] J. A. Villarreal-Rodriguez, L. G. Mancillas Adame, J. Maldonado-Sanchez, A. Guzmán-López, O. R. Treviño-Montemayor, J. G. Gonzalez-Gonzalez, D. Saldívar-Rodríguez. A randomized controlled trial comparing acarbose vs. insulin therapy for gestational diabetes in individuals with inadequate glycemic control by diet alone[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 552-555.
[15] J. Ogawa, S. Suzuki. Risk factors of self-interruption of medications for mental disorders in pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 576-578.
No Suggested Reading articles found!